摘要:
The present invention relates to new dihydropteridinones of the formula (I) 1 wherein the groups X, R1, R2, R3, R4, R5 and R7 have the meanings given in the claims and specification, the isomers thereof, processes and intermediates for preparing these dihydropteridinones as well as the use thereof as pharmaceutical compositions.